Drug intelligence / Profile preview

PSORI-CM01 decoction

Development stage
Unknown
Lead developer
Guangdong Provincial Hospital of Traditional Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

PSORI-CM01 decoction is a traditional Chinese medicine (TCM) herbal formulation developed by the Guangdong Provincial Hospital of Chinese Medicine (originally formulated by Xuan Guowei) for the treatment of psoriasis vulgaris. It is an optimized and simplified version of the 10-herb "Yinxieling" formula, containing seven active herbal ingredients: Radix Paeoniae Rubra (red peony root), Smoked Plum (Prunus mume), Chloranthus spicatus, Radices Lithospermi (Arnebia euchroma), Curcuma zedoaria, Rhizoma Smilacis Glabrae, and Glycyrrhiza uralensis (licorice). PSORI-CM01 is designed to promote blood circulation, remove blood stasis, and cool and detoxify the blood. It has been shown to inhibit keratinocyte proliferation, downregulate cyclin B2, and modulate inflammatory pathways such as the Th17/IL-23 axis and PI3K/Akt/mTOR signaling.

Other names
PSORI-CM01 decoctionPSORI-CM-01 decoctionPSORI-CM 01 decoctionPSORI-CM01 formulaPSORI-CM-01 formulaPSORI-CM 01 formulaPSORI-CM01 granulesPSORI-CM-01 granulesPSORI-CM 01 granulesPSORI-CMO1 decoctionPSORI-CMO-1 decoctionPSORI-CMO 1 decoctionYinxiekang Pian
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CDK4 (Cyclin-dependent kinase 4)CCNB2 (Cyclin B2)GSK3 (Glycogen synthase kinase 3 beta)IL12 (Interleukin-12)IL-6 (Interleukin 6)mTOR (Mammalian target of rapamycin kinase)RELA (Nuclear Factor Kappa B Subunit p65)STAT1 (Signal transducer and activator of transcription protein 1)STAT3 (Signal Transducer and Activator of Transcription 3)

Beyond the preview

Go deeper on PSORI-CM01 decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSORI-CM01 decoction.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call